Our findings are in line with previous data linking the up-regulation of the WNT/β-catenin signaling pathway to the development of certain brain tumors, e.g. medulloblastomas frequently harboring mutations in the CTNNB1 gene encoding β-catenin [58] and glioblastomas [59]. This evidence concerns the gene CTNNB1 and glioblastoma.